Generic placeholder image

Recent Patents on Inflammation & Allergy Drug Discovery


ISSN (Print): 1872-213X
ISSN (Online): 2212-2710

New Developments in Oral Vaccines and Mucosal Adjuvants

Author(s): Jose L. Subiza, David El-Qutob and Enrique Fernandez-Caldas

Volume 9 , Issue 1 , 2015

Page: [4 - 15] Pages: 12

DOI: 10.2174/1872213X09666150211122313

Price: $65


Mucosal immunity is the first line of defence of the organism against several pathogens and, at the same time, it is of critical importance in allergic diseases. Oral vaccines have been developed with the aim of enhancing the immune response to pathogens and for the treatment of allergic diseases. One of the major issues concerning oral vaccines is the use of oral adjuvants which could facilitate antigen presentation with the consequent induction of an effective immune response. The present review consists of an analysis, point by point, of the different patents that have been presented in the last 12 months in the different agencies: European (EP), US, and World Intellectual Property Organization (WIPO) and a general analysis of the future developments and trends in this emerging area.

Keywords: Adjuvant, allergic diseases, immunoglobulin, mucosa, mucosal immunity, oral vaccines.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy